How Respiratory Scientists Actually Choose PFT Reporting Software: A Practitioner's Buying Guide for 2026

How Respiratory Scientists Actually Choose PFT Reporting Software: A Practitioner's Buying Guide for 2026

Choosing the right pulmonary function test software is not simply a procurement decision. It is a clinical one. The software that sits at the centre of your respiratory lab shapes how data is captured, how reports are generated, how standards are met, and ultimately, how patients are cared for. Yet most buying guides treat this like any other IT purchase. This one does not. This guide is written from the perspective of the people who actually use these systems every day: respiratory scientists.

TL;DR

  • PFT reporting software directly affects clinical accuracy, lab efficiency, and accreditation compliance.

  • The most overlooked evaluation criteria are vendor lock-in, integration capability, and how well the software reflects current ATS/ERS guidelines.

  • Machine learning is beginning to influence how pulmonary function data is interpreted, making software adaptability a forward-looking requirement.

  • Switching platforms is simpler than most labs expect when the right migration support is in place.

  • Rezibase is a cloud-based, vendor-neutral platform built by respiratory scientists, trusted across Australian and UK hospital networks.

Why Does PFT Software Choice Actually Matter Clinically?

PFT reporting software is not a passive data recorder. It actively influences clinical outcomes by determining which values are selected, how normal ranges are applied, and how results are structured for physician review.

According to a 2021 study published in Scientific Reports, different selection methods for reporting spirometric parameters such as FEV1 and FVC can yield meaningfully different results when compared against current ATS/ERS standards. The study noted that the method used to select and report these values matters in a measurable way. This finding is worth pausing on: the software logic embedded in your reporting system is not a neutral background process. It is a clinical variable.

As noted by Respiratory Therapy, spirometry has proven to be a valuable tool across pulmonary health, from confirming diagnoses to tracking disease progression. The integrity of that tool depends heavily on the system used to capture and report its outputs.

What Should Be on Your Evaluation Checklist?

Most labs approach software evaluation with a feature list. A better approach is to evaluate against clinical and operational risk.

Clinical accuracy and standards alignment

  • Does the software apply ATS/ERS reporting logic correctly and consistently?

  • Is the normal values library current, configurable, and regularly updated?

  • Can the system handle multiple reference equations across different patient populations?

Vendor neutrality

  • Can you import data from any spirometer or device brand?

  • Are you locked into purchasing specific equipment to use the software?

Workflow integration

  • Does it connect with your Patient Administration System (PAS) or Electronic Medical Record (EMR)?

  • Does it eliminate double data entry, which is a known source of clinical error?

Accreditation readiness

  • Does it support documentation, audit trails, quality control, and non-conformance tracking?

  • Does it align with ISO 15189 and TSANZ/NATA requirements?

Cloud vs. on-premise

  • Is the system accessible remotely without local IT infrastructure?

  • Who manages updates, backups, and security?

How Is Machine Learning Changing PFT Reporting?

A 2021 paper published in Frontiers in Physiology explored the application of machine learning in pulmonary function assessment. The authors found that ML has potential to assist clinicians in interpreting PFT data, with applications ranging from pattern recognition in spirometry to automated classification of obstructive and restrictive patterns. The paper noted that this is an area of active development and that the field is still evolving.

What this means practically for software buyers: the platforms you evaluate today should have the architectural flexibility to incorporate these capabilities as they mature. Closed, legacy systems built around static logic are less likely to adapt. Cloud-based platforms with modular design are better positioned.

What Does the Market Look Like in 2026?

The global pulmonary function testing systems market was valued at USD 2.9 billion in 2024 and is projected to grow at a CAGR of 6.6% through 2034, according to GM Insights. This growth is being driven by rising rates of chronic respiratory disease, increasing awareness of early diagnosis, and expanding access to diagnostic services in both developed and emerging markets.

For labs, this growth means more patients, more data, and more pressure on reporting systems to perform reliably at scale. Software that struggles under volume or requires manual workarounds will become an increasing liability.

How Should Labs Think About Implementation?

Implementation science, as outlined by the Pulmonary Diagnostic Laboratory Resource Center, emphasises that adopting new processes in clinical settings requires more than technical installation. It involves change management, staff training, and alignment with existing workflows.

The practical implication: when evaluating pulmonary function test software, ask vendors not just what the software does, but how they support the transition. A well-supported implementation reduces disruption and accelerates time to value.

For labs considering a move away from legacy platforms like Respiro, the concern is often around data migration. In practice, when a platform is designed with migration in mind, the process is far more straightforward than it appears. Existing patient records, historical results, and device data can be transferred cleanly, and a good vendor will guide you through each step without leaving your team to figure it out alone.

Where Does Rezibase Fit?

Rezibase is a cloud-based respiratory and sleep reporting platform built by respiratory scientists Peter Rochford and the late Jeff Pretto. It was designed specifically to address the frustrations that practitioners encounter with general-purpose or manufacturer-tied software.

Key features relevant to this buying guide:

  • Vendor-neutral data import: The Magic Import function pulls data from any device brand, extracting discrete values including flow-volume loops automatically.

  • ATS-aligned reporting: Built-in algorithms support reporting according to ATS guidelines, with AI-assisted report writing and medical dictation.

  • Normal Values Library: Pre-configured and regularly updated to reflect current reference standards.

  • Accreditation module: Covers documents, training, non-conformance, action plans, audits, and quality control aligned with TSANZ/NATA and ISO 15189.

  • Full integration: Connects with PAS, EMR, DICOM, hospital finance, and electronic orders systems.

  • Cloud-based SaaS: No local servers, no IT overhead, accessible from anywhere.

Rezibase is used across more than 35 sites, including NHS hospitals in the UK and NSW Health facilities in Australia. It covers both respiratory and sleep reporting, which is a meaningful operational advantage for labs managing both service lines.

Pricing is transparent, all-inclusive, and month-to-month with no lock-in contracts. A 30-day free trial is available.

Frequently Asked Questions

What is the most important feature to look for in PFT reporting software?
Standards alignment and vendor neutrality. Software that applies ATS/ERS logic correctly and works with any device brand reduces clinical risk and avoids equipment lock-in.

Is switching from Respiro to another platform complicated?
Not necessarily. With the right migration support, historical data and patient records can be transferred cleanly. The key is choosing a vendor who treats migration as part of the service, not an afterthought.

Does cloud-based PFT software meet hospital security requirements?
Yes, when built to enterprise standards. Platforms like Rezibase can also be deployed on-premise for hospitals with specific data sovereignty requirements.

How do I evaluate whether a platform supports accreditation?
Look for built-in tools for document control, audit trails, non-conformance tracking, and quality control. Alignment with ISO 15189 and TSANZ/NATA is a baseline requirement for Australian labs.

Will AI and machine learning affect how PFT software works?
Research published in Frontiers in Physiology suggests ML has real potential in pulmonary function assessment. Choosing a platform with modern, adaptable architecture positions your lab to benefit as these capabilities develop.

Can one platform manage both respiratory and sleep reporting?
Some platforms do. Rezibase covers both, which simplifies administration, reduces vendor overhead, and keeps patient data in a single system.

What should I ask a vendor during a demo?
Ask about data migration, integration with your current hospital systems, how normal values are updated, and what accreditation support is included. Then ask for a reference site.

About Rezibase

Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, built by respiratory scientists for respiratory scientists. Trusted by over 35 sites including NHS and NSW Health, it offers vendor-neutral data import, ATS-aligned reporting, full accreditation support, and seamless hospital system integration. Rezibase is backed by Cardiobase, a healthcare technology company with 37 years of experience in clinical diagnostics.

Explore Rezibase at rezibase.com or start a 30-day free trial today.

References

Role-Based Access Control and Governance Models for Enterprise Respiratory Platforms: Balancing Clinician Autonomy With Organisational Compliance at Scale ›

Role-Based Access Control and Governance Models for Enterprise Respiratory Platforms: Balancing Clinician Autonomy With Organisational Compliance at Scale ›